Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial. - Strati P; Feng L; Westin JR; Nair R; Fayad LE; Rodriguez MA; Chihara D; Malpica L; Henderson J; Gallardo M; Rivera M; Wang I; et al. (Nature communications, 2025)